Review
Aug 2026
AI-based augmentation of oncology clinical trials.
It is argued that achieving the potential of AI in oncology clinical trials will require rigorous prospective validation, harmonized regulatory standards, and coordination among clinicians, trialists, regulators, industry and patients.
Andrea Villa, A. Eadie, David Synnott et al.
· Nature Reviews Clinical Onco... · 0 citations